医师发起的研究性器械豁免试验中,自动化软件规划的開窗腔内动脉瘤修复术患者的术中及围手术期结果
本研究在医师发起的研究性器械豁免试验中,纳入30例不适合开放手术的近肾腹主动脉瘤患者,采用自动化规划软件设计開窗支架並行開窗腔内动脉瘤修复术。30例支架均成功植入,分支血管保留率97%(84/87),30天死亡率为6.7%(2/30),30天主要不良事件率为16.7%(5/30),30天内无IA型或III型内漏、破裂或中转开放手术。作者认为该自动化规划软件能准确高效地确定開窗位置,简化规划流程。
要点
- 30例近肾腹主动脉瘤患者均成功植入自动化软件规划的開窗支架,分支血管保留率97%(84/87)。
- 30天死亡率为6.7%(2/30),两例死亡均与动脉瘤无关;30天主要不良事件率为16.7%(5/30)。
- 30天内无IA型或III型内漏、破裂或中转开放手术。
核心结论
- 自动化開窗腔内修复规划软件能准确高效地确定重要分支动脉的開窗位置,从而简化规划流程并促进開窗腔内修复术的实施。
- 经过验证的自动化開窗腔内修复规划可能有助于将这一有益疗法带给大多数近肾腹主动脉瘤患者。
研究设计与样本
- 研究为正在进行的医师发起的研究性器械豁免临床试验中的自动化规划组,纳入不适合开放手术的近肾腹主动脉瘤患者并接受開窗腔内动脉瘤修复术。
- 共30例患者(美国麻醉医师协会分级≥3级)入组并接受自动化软件规划的開窗支架治疗,平均年龄74±7岁(范围61-86岁)。
- 患者特异性開窗尺寸和位置由自动化规划软件根据患者影像数据和算法确定,算法考虑支架输送系统与成角主动脉解剖的相互作用。
- 多种制造商的标准市售腹主动脉瘤支架由医师根据自动化支架规划在台旁改造,采用患者特异性三维打印圆柱模板形式。
- 支架通常包括肠系膜上动脉和双侧肾动脉的開窗。
主要发现
- 平均动脉瘤直径为61.3 mm(范围49-96 mm),平均肾下颈长度为6.1 mm(范围2-15 mm)。
- 在索引手术中,100%(30/30)的患者特异性、医师改造支架成功植入,分支血管保留率为97%(84/87),最终近端密封区平均长度为41.9 mm(范围27.3-60.6 mm)。
- 三支肾动脉在索引手术中未置管,原因在于与支架规划无关的并发症。
- 这些高危近肾腹主动脉瘤患者的30天死亡率为6.7%(2/30),两例死亡均与动脉瘤无关。
- 30天主要不良事件率为16.7%(5/30),截至30天无IA型或III型内漏、破裂或中转开放手术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Fenestrated endovascular aneurysm repair (FEVAR) has been used successfully to treat patients with juxtarenal abdominal aortic aneurysms (JAAAs). Barriers to wide adoption of FEVAR include complexity in planning of fenestration locations on endografts. The purpose of this study was to validate the use of automated planning software to design fenestrated endografts and to treat patients with complex abdominal aortic aneurysms. METHODS: Patients with JAAA who were not candidates for open repair were enrolled into the automated planning arm of an ongoing investigational device exemption clinical trial and treated with FEVAR. Patient-specific fenestration size and location were determined by automated planning software using patient imaging data and algorithms that account for the interaction between the endograft delivery system and angulated aortic anatomy. Standard, off-the-shelf abdominal aortic aneurysm endografts from multiple manufacturers were modified on the back table by the physician according to the automated graft plan in the form of a patient-specific three-dimensional printed cylindrical template. Endografts typically included fenestrations for the superior mesenteric artery and both renal arteries. Procedural, perioperative, and long-term clinical and imaging data were collected per protocol. RESULTS: Thirty nonoperative JAAA candidate patients (American Society of Anesthesiologists class ≥3) were consented and treated with fenestrated endografts planned by automated software. The mean age was 74 ± 7 (61-86) years. The mean aneurysm diameter was 61.3 mm (range, 49-96 mm), and the mean infrarenal neck length was 6.1 mm (range, 2-15 mm). At the index procedure, 100% (30/30) of the patient-specific, surgeon-modified grafts were implanted with preservation of 97% (84/87) of branch vessels and a mean final proximal seal zone length of 41.9 mm (range, 27.3-60.6 mm). Three renal arteries were not cannulated during the index procedure because of complications not related to graft planning. The 30-day mortality rate in these high-risk JAAA patients was 6.7% (2/30), and both deaths were unrelated to the aneurysm. The 30-day major adverse event rate was 16.7% (5/30). There were no type IA or type III endoleaks, ruptures, or conversions to open surgery through 30 days. CONCLUSIONS: This automated FEVAR planning software accurately and efficiently identifies fenestration locations for vital branch arteries, thus simplifying the planning process and facilitating the FEVAR procedure. Validated automated FEVAR planning could help bring this beneficial therapy to most patients harboring JAAAs.
引用
- Starnes BW, Tatum B, Singh N, et al. Procedural and perioperative results in patients treated with fenestrated endovascular aneurysm repair planned by automated software in a physician-sponsored investigational device exemption trial of physician-modified endografts. J Vasc Surg. 2018. PMID: 29706473. doi:10.1016/j.jvs.2018.02.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。